Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment

by Hines DM, Ding Y, Wade RL, Beaubrun A, Cohen JP
Published 2019-11-01

Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors

by Hines DM, Rane P, Patel J, Harrison DJ, Wade RL
Published 2018-12-01

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterole...

by Chen CC, Rane PB, Hines DM, Patel J, Harrison DJ, Wade RL
Published 2018-12-01

Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy

by Zhu J, Kirkham HS, Ayer G, Chen CC, Wade RL, Karkare SU, Robson CH, Orange JS
Published 2017-12-01

Demographic And Clinical Characteristics Of Patients Prescribed Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Therapy And Patients Whose Current Lipid-Lowering Therapy Wa...

by Baum SJ, Wade RL, Xiang P, Arellano J, Cerezo Olmos C, Nunna S, Chen CC, Carter CM, Desai NR
Published 2019-11-01